Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Combined Investigation of the Protective Impact of the NOF/Q Antagonist LY-2940094 on Stress-induced Depression- and Anxiety-related Phenotypes in Humans

NCT06786637 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT06786637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06786637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Combined Investigation of the Protective Impact of the NOF/Q Antagonist LY-2940094 on Stress-induced Depression- and Anxiety-related Phenotypes in Humans
Lead sponsor
Mclean Hospital
Phase
Phase 2
Overall status
Withdrawn
Start date
June 30, 2025
Completion date
August 31, 2026
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, depression - major depressive disorder, stress